Publication | Closed Access

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

UrologySurgical OncologyCancer CentersGenitourinary CancerMedicineCancer ManagementFrench FederationRandomized TrialCancer TreatmentOncologyRadiation Oncology